Breast-Ovarian Cancer Combined Gene Detection Kit
A molecular diagnostic solution designed for the combined detection of genetic markers associated with hereditary breast and ovarian cancer.
GENETIC TESTING SOLUTIONProduct Overview
The Breast-Ovarian Cancer Combined Gene Detection Kit is designed for molecular genetic analysis of genes associated with hereditary breast and ovarian cancer susceptibility.
Hereditary breast and ovarian cancer syndrome is associated with pathogenic variants in genes involved in DNA repair and genomic stability. Genetic testing can help identify inherited variants that may contribute to an increased risk of developing certain cancers.
This kit is intended to support molecular biology workflows and genetic research involving hereditary cancer-associated genes. Refer to the manufacturer's technical documentation for the exact gene panel, mutation coverage, sample requirements and analytical method.

Key Features & Benefits
Combined Gene Detection
Designed for the analysis of multiple hereditary cancer-associated genetic targets.
Molecular Analysis
Supports molecular genetic testing and laboratory research workflows.
Cancer Genetics
Relevant to research into hereditary breast and ovarian cancer susceptibility.
Laboratory Application
Designed for professional molecular biology laboratory environments.
Genetic Background: Breast & Ovarian Cancer
Hereditary breast and ovarian cancer can be associated with inherited genetic variants affecting cellular DNA repair mechanisms. The BRCA1 and BRCA2 genes are among the most extensively studied genes in this field.
Alterations in these genes can impair normal DNA repair processes and contribute to genomic instability. Genetic analysis can help researchers investigate inherited cancer susceptibility and molecular mechanisms associated with tumor development.
Hereditary cancer genetics, DNA repair pathways, genetic variation and molecular oncology.
Research & Laboratory Applications
- Hereditary breast and ovarian cancer genetic research.
- Molecular analysis of cancer-associated genetic variants.
- BRCA-related molecular research, where included in the validated panel.
- DNA repair pathway investigations.
- Genetic susceptibility and molecular oncology studies.
- Research into inherited cancer-associated mutations.
Technical Specifications
| Product Name | Breast-Ovarian Cancer Combined Gene Detection Kit |
| Product Category | Molecular Diagnostics |
| Application | Hereditary Breast and Ovarian Cancer Gene Detection |
| Target | Cancer-associated genetic markers |
| Testing Method | Molecular genetic analysis (refer to product documentation) |
| Sample Type | Refer to manufacturer's instructions |
| Kit Size | Refer to product packaging |
| Storage Conditions | Refer to manufacturer's instructions |
Important Information
Genetic testing results should be interpreted by qualified healthcare professionals or genetic specialists in accordance with validated laboratory procedures. The presence of a genetic variant does not necessarily indicate that an individual will develop cancer. Clinical interpretation depends on the specific variant, its classification and the individual's medical and family history. Consult the product documentation for validated intended use, gene coverage, analytical performance and sample requirements.
Discover Molecular Diagnostic Solutions at Gentaur
Explore molecular biology reagents, genetic testing kits and laboratory diagnostic solutions.
EXPLORE PRODUCTSContact our team: info@gentaur.com